Latest Insider Transactions at Pulse Biosciences, Inc. (PLSE)
This section provides a real-time view of insider transactions for Pulse Biosciences, Inc. (PLSE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Pulse Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Pulse Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2024
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,206
+4.14%
|
$24,266
$11.0 P/Share
|
|
Sep 24
2024
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,000
+3.1%
|
$33,000
$11.0 P/Share
|
|
Jul 19
2024
|
Burke Thomas Barrett President and CEO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,086
+4.37%
|
$11,946
$11.0 P/Share
|
|
Jul 03
2024
|
Maky Zanganeh Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
60,242
+8.3%
|
-
|
|
Jul 03
2024
|
Robert W Duggan Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
118,332
+10.95%
|
-
|
|
Jul 03
2024
|
Robert W Duggan Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
5,187,824
+10.95%
|
-
|
|
Jul 03
2024
|
Kevin Patrick Danahy Chief Commercial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
650
+1.75%
|
-
|
|
Jul 03
2024
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,207
+4.33%
|
-
|
|
Jul 03
2024
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,000
+3.2%
|
-
|
|
Jul 03
2024
|
Burke Thomas Barrett President and CEO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,086
+8.92%
|
-
|
|
May 20
2024
|
Burke Thomas Barrett President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$80,000
$8.56 P/Share
|
|
Dec 12
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
17,999
+0.05%
|
$161,991
$9.15 P/Share
|
|
Dec 11
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
90,118
+0.24%
|
$811,062
$9.36 P/Share
|
|
Dec 08
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
116,656
+0.32%
|
$1,049,904
$9.54 P/Share
|
|
Dec 07
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
74,852
+0.2%
|
$673,668
$9.19 P/Share
|
|
Dec 06
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
82,813
+0.23%
|
$745,317
$9.06 P/Share
|
|
Dec 06
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,933
+0.03%
|
$49,665
$5.95 P/Share
|
|
Dec 05
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
66,021
+15.81%
|
$594,189
$9.34 P/Share
|
|
Dec 04
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
27,000
+8.64%
|
$270,000
$10.38 P/Share
|
|
Dec 04
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,347
+0.06%
|
$403,470
$10.66 P/Share
|
|
Dec 01
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
45,600
+14.99%
|
$410,400
$9.07 P/Share
|
|
Nov 30
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
152,944
+41.8%
|
$1,376,496
$9.06 P/Share
|
|
Nov 29
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
60,000
+50.0%
|
$540,000
$9.21 P/Share
|
|
Nov 29
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
158,600
+0.43%
|
$1,427,400
$9.44 P/Share
|
|
Nov 29
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+0.0%
|
$8,335
$5.95 P/Share
|
|
Nov 28
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
124,397
+0.34%
|
$995,176
$8.98 P/Share
|
|
Nov 17
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
20,241
+0.02%
|
$121,446
$6.1 P/Share
|
|
Nov 16
2023
|
Kevin Patrick Danahy Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,393
+4.54%
|
$32,358
$6.51 P/Share
|
|
Nov 15
2023
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Open market or private purchase
|
Indirect |
13,539
+31.4%
|
$67,695
$5.93 P/Share
|
|
Nov 15
2023
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Open market or private purchase
|
Direct |
4,261
+2.8%
|
$21,305
$5.86 P/Share
|
|
Nov 13
2023
|
Maky Zanganeh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,075
+6.0%
|
$152,150
$2.14 P/Share
|
|
Nov 07
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,265
+0.02%
|
$66,325
$5.95 P/Share
|
|
Aug 25
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+0.0%
|
$8,335
$5.95 P/Share
|
|
Jul 25
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+0.0%
|
$8,335
$5.95 P/Share
|
|
Jul 07
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67,133
+0.09%
|
$268,532
$4.05 P/Share
|
|
Jul 05
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+0.18%
|
$130,000
$2.14 P/Share
|
|
Jun 14
2023
|
Robert W Duggan Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
81,025
+14.14%
|
$162,050
$2.05 P/Share
|
|
Jun 14
2023
|
Robert W Duggan Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
5,683,163
+13.6%
|
$11,366,326
$2.05 P/Share
|
|
Jun 12
2023
|
Darrin Uecker Chief Technology Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
7,365
+0.83%
|
$14,730
$2.05 P/Share
|
|
Jun 09
2023
|
Maky Zanganeh Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
86,668
+9.86%
|
$173,336
$2.05 P/Share
|
|
May 25
2023
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,243
+16.34%
|
$2,486
$2.05 P/Share
|
|
May 25
2023
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
10,935
+4.52%
|
$21,870
$2.05 P/Share
|
|
May 09
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
10,022,937
+24.79%
|
$60,137,622
$6.51 P/Share
|
|
Oct 07
2022
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Open market or private purchase
|
Indirect |
22,010
+44.74%
|
$44,020
$2.26 P/Share
|
|
Oct 07
2022
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Open market or private purchase
|
Direct |
8,770
+15.93%
|
$17,540
$2.29 P/Share
|
|
Sep 30
2022
|
Kevin Patrick Danahy Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
6,500
+50.0%
|
$13,000
$2.3 P/Share
|
|
Jun 09
2022
|
Darrin Uecker Chief Technology Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
7,365
+5.09%
|
-
|
|
Jun 09
2022
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,243
+16.34%
|
-
|
|
Jun 09
2022
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
10,935
+22.57%
|
-
|
|
Jun 09
2022
|
Maky Zanganeh Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
86,668
+16.39%
|
-
|